Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Four new substances—minoxidil, ferrimanitol ovalbumin, clarithromycin, and glucosamine-hydrochloride—can cause occupational asthma.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Atopic dermatitis increases the risk of some autoimmune diseases.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

Foxn1 gene regulation is crucial for thymus development but not for hair growth.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Thyroid hormone imbalances can cause hair loss in alopecia patients.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.